Mutation analysis in liver tumor organoids revealed mutations in key cancer-associated genes, such as TP53 and KRAS, supporting their relevance for studying key molecular drivers of biliary tract cancers and drug response modeling. Here, TP53 is linked to biliary tract cancer.